Arkolith/Insider Trading/KURA/Form 4

Powl Brian T.

Chief Commercial OfficerKura Oncology, Inc. (KURA) · full profile →Form 4 · filed Sep 29, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$79K
Net Open-Market Flow
-$79K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 29, 2025Sell(S)9K$8.94$79K100K
Sep 27, 2025Grant(A)49K—$0109K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-223667) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML